iSTAR Medical logo.png
iSTAR Medical Expands International Commercial Rollout of MINIject® with Successful First Implants Completed in Australia
10 janv. 2024 03h00 HE | iSTAR Medical
For immediate release iSTAR Medical Expands International Commercial Rollout of MINIject® with Successful First Implants Completed in Australia WAVRE, Belgium — 10 January 2024: iSTAR Medical, a...
iSTAR Medical logo.png
iSTAR Medical continues European expansion with first MINIject® surgeries in the Netherlands
22 déc. 2023 07h00 HE | iSTAR Medical
For immediate release iSTAR Medical continues European expansion with first MINIject® surgeries in the Netherlands WAVRE, Belgium — 22 December 2023: iSTAR Medical, a medtech company delivering...
iSTAR Medical logo.png
iSTAR Medical conducts first MINIject® surgeries in Ireland, expanding commercial rollout in Europe
31 oct. 2023 04h00 HE | iSTAR Medical
For immediate release iSTAR Medical conducts first MINIject® surgeries in Ireland, expanding commercial rollout in Europe WAVRE, Belgium — 31 October 2023: iSTAR Medical, a medtech company...
iSTAR Medical logo.png
iSTAR Medical presents positive three-year results for MINIject® from STAR-GLOBAL trial
07 sept. 2023 03h00 HE | iSTAR Medical
For immediate release iSTAR Medical presents positive three-year results for MINIject® from STAR-GLOBAL trial Interim three-year follow-up data further demonstrate consistent safety and efficacy of...
iSTAR Medical logo.png
iSTAR Medical initiates international STAR-VI trial for the use of MINIject in conjunction with cataract surgery
15 mars 2023 07h00 HE | iSTAR Medical
MINIject® is the only commercially available MIGS implant targeting the supraciliary space Clinical data show positive, consistent results up to two-year follow-up in patients across Europe, Asia, and...
iSTAR Medical logo.png
iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway
01 déc. 2022 03h00 HE | iSTAR Medical
For immediate release iSTAR Medical Expands Commercial Rollout of MINIject with First Surgeries in Sweden and Norway The only commercially available MIGS device currently targeting the supraciliary...
iSTAR Medical logo.png
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
08 juin 2022 07h00 HE | iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
iSTAR Medical logo.png
iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials
08 juin 2022 02h00 HE | iSTAR Medical
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
iSTAR Medical logo.png
iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland
10 mai 2022 02h00 HE | iSTAR Medical
For immediate release iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland The only commercially available MIGS device currently targeting the supraciliary...
iSTAR Medical logo.png
iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK
28 mars 2022 02h00 HE | iSTAR Medical
For immediate release iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK UK patients and surgeons now able to benefit from the only commercially available MIGS device...